MacroGenics, Inc.

MGNX

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
September 24, 2024

Days Left:
-89

calendar

MacroGenics, Inc. Form












Class Action Lawsuit List does not share your information with others. There is no cost or obligation for you to submit.

Allegations

During the class period, Defendants made material misrepresentations about the safety data from its TAMARACK Phase 2 study of vobramitamab duocarmazine. On May 9, 2024, the investing public learned that the drug was significantly more dangerous than defendants had previously represented. Following this news, MGNX’s stock declined 77.4% due to a drop of $11.36/share.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of MacroGenics purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in MacroGenics during the relevant time frame, you have until September 24, 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Active Cases

Ticker Symbol Company Name Join Deadline Join
TD The Toronto-Dominion Bank December 23, 2024 Join
WOLF Wolfspeed, Inc. January 17, 2025 Join
SUI Sun Communities, Inc. February 10, 2025 Join
SAVA Cassava Sciences, Inc. February 10, 2025 Join
APLT Applied Therapeutics, Inc. February 18, 2025 Join